[Sci-tech-public] STS Program Special Seminars Invitation

[Gus Zahariadis]

Dear STS Community,

The STS Program will be holding three Special Seminars in the next two weeks.  

You are cordially invited to attend the Special Seminars listed below.  We look forward to your attendance and hope you enjoy these talks.


Jose Ragas, Cornell U

Monday, December 7

4pm – E51-095

From Citizens to Algorithms: ID Cards and Global Biometrics in the Age of Surveillance

Over the last century and a half, experts from different fields have attempted to design a mechanism capable of establishing particular identities for each individual in a given territory. Biometrics is the latest attempt to fulfill this utopian vision of universal identification by using technology as an effective identifier of people’s bodies. This talk revisits the origins and limits of these efforts by examining the genealogy of ID cards from the Global South. By reversing the conventional approach of technologies of information disseminating from the North to the South, I offer  a different  perspective in  order to  introduce  a more  complex and  nuanced analysis of how users in different settings interacted with artifacts originally intended to monitor their movements and categorize them according to certain scientific parameters.

 

Marissa Mika, U of San Francisco

Monday, December 14

4pm – E51-095

Cobalt Blues: The Half Life of Technology Transfer

What happens when oncology's technologies travel? Focusing on the history of cancer care in Uganda for the past 50 years, I show how the historically situated techno-politics of a one-time radiotherapy donation continue to shape the ethical and practical realities of cancer care today in one corner of the Global South. This is a meditation on the "half life" of machines, technocratic imaginaries, and the limits of repair in a unequal world.



Dwai Banerjee, Dartmouth College

Wednesday, December 16

4pm – E51-095

“Markets and molecules: biopharmaceutical rights in the global south”

The Indian pharmaceutical industry has historically manufactured low-cost drugs for the global poor.  In this talk, I show how as new drug access controversies in India focus on biopharmaceutical therapies, they reveal new flows of international capital, emergent genetic technologies, and increasingly coercive trade regimes that together favor multi-national corporate oligopolies.  In turn, the rise of such oligopolies imperils the future availability of essential life-saving drugs for the work of global public health.  My aim here is to demonstrate how the future of the right to drug access rests uneasily, and potentially calamitously, in a shifting balance of power between global south interests and Euro-American pharmaceutical capital.



Please feel free to contact me with any questions you may have.
Thank you,
Gus
_____________________________________________
Gus Zahariadis
Assistant to the Director
Program in Science, Technology, and Society

T: (617) 253-3452
F: (617) 258-8118




-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.mit.edu/pipermail/sci-tech-public/attachments/20151202/a31fd96d/attachment-0001.html
-------------- next part --------------
A non-text attachment was scrubbed...
Name: smime.p7s
Type: application/pkcs7-signature
Size: 1852 bytes
Desc: not available
Url : http://mailman.mit.edu/pipermail/sci-tech-public/attachments/20151202/a31fd96d/attachment-0001.bin